CD19 and neoplasm: Statistically significant differences were seen between zinc and CD19+CD69+ tumor, CD4+CD25+ node T lymphocytes and Cu and: CD3+CD69+, CD4+PD-1, CD8+PD-1 tumor, and CD4+PD-1, CD8+PD-1 node T lymphocytes.